Full-Time

Senior Manager

Technology, Research Data and Analytics, Rdna

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Data Management
Data Analysis
Data & Analytics
Required Skills
Agile
Python
R
SQL
Machine Learning
Tableau
Databricks
Data Analysis
Requirements
  • Master’s degree and 8 to 10 years of Life Sciences, Computer Science, IT, Computational Chemistry/Cheminformatics, Computational Biology/Bioinformatics or related field, OR
  • Bachelor’s degree and 10 to 14 years of Life Sciences, Computer Science, IT, Computational Chemistry/Cheminformatics, Computational Biology/Bioinformatics or related field, OR
  • Diploma and 14 to 18 years of Life Sciences, Computer Science, IT, Computational Chemistry/Cheminformatics, Computational Biology/Bioinformatics or related field
  • Familiarity with data analytics and scientific computing platforms such as Databricks, Dash, Streamlit, RShiny, Spotfire, Tableau and related programming languages like SQL, python, R
  • Excellent problem-solving skills and a passion for tackling complex challenges in drug discovery with technology and data
  • Demonstrated experience building strong teams with consistent practices in a matrix organization
  • In-depth knowledge of Agile processes and principles for coordinated solutions and teams via SAFe
Responsibilities
  • Lead and handle diverse teams within a matrixed organization.
  • Collaborate with geographically dispersed teams, including those in the US, EU, and other international locations.
  • Provide technology delivery leadership and domain expertise for RDNA product teams and capabilities.
  • Partner with Research and Technology leaders to create technology delivery strategy and prioritized agenda for RDNA.
  • Ensure scientific data operations are scoped into building Research-wide Artificial Intelligence/Machine Learning capabilities.
  • Provide leadership for the creation of functional analytics dashboards and fit-for-purposes applications for quantitative research, scientific analysis and business intelligence (via Spotfire, Tableau, Dash, Posit, Streamlit, RShiny, etc.).
  • Manage a suite of custom internal platforms, commercial off-the-shelf (COTS) software, and systems integrations.
  • Follow global standards and practices.
  • Foster a culture of collaboration, innovation, and continuous improvement.
  • Develop talent, motivate the team, delegate effectively, champion diversity within the team and act as a role model of servant leadership.
  • Manage, grow, and develop the Amgen Technology team in India, ensuring global ways of working are embedded in the local organization.
  • Understand the decision-making process, workflows, and business and information needs of business partners and collaborators.
  • Work with Product Owners, Service Owners and/or delivery teams to ensure that delivery matches commitments, acting as a partner concern point and facilitating communication when service commitments are not met.
  • Ensure communication of key performance metrics and analysis of unmet needs.
  • Ensure ongoing alignment with strategy, compliance, and regulatory requirements for technology investments and services.
  • Facilitate standard methodology sharing, ensuring ongoing alignment with the Technology & Digital strategy.
  • Oversee operating budgets and product team budgets, ensuring regular review of actuals and latest estimates, managing according to agreed governance.
  • Ensure alignment of Technology service plans across organization.
  • Provide education to new partners with regards to Data and Analytics service offerings.
  • Remain accountable for ensuring overall organizational compliance to quality/compliance requirements such as GXP and Privacy.
Desired Qualifications
  • Familiarity with advanced analytics, AI/ML and scientific computing infrastructure, such as High-Performance Compute (HPC) environments and clusters (e.g., SLURM, Kubernetes)
  • 6+ years of experience in implementing and supporting biopharma scientific research data analytics.
  • Experience in a leadership role within a pharmaceutical or technology organization
  • Demonstrated expertise in a scientific domain area and related technology needs
  • Understanding of scientific data strategy, data governance, data infrastructure
  • Experience with cloud (e.g. AWS) and on-premise compute infrastructure
  • Strong analytical/critical-thinking and decision-making abilities
  • Ability to work effectively in a fast-paced, dynamic environment
  • Experience in establishing business partnerships and IS governance practices involving senior business collaborators.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.